,
Seider, Michael I.
Berry, Duncan E.
Schefler, Amy C.
Materin, Miguel
Stinnett, Sandra
Mruthyunjaya, Prithvi http://orcid.org/0000-0003-1087-9736
Funding for this research was provided by:
Heed Foundation
National Eye Institute (P30-026877)
Research to Prevent Blindness (na)
Article History
Received: 5 June 2019
Revised: 26 October 2019
Accepted: 29 October 2019
First Online: 6 December 2019
Compliance with ethical standards
:
: Prithvi Mruthyunjaya serves as a consultant for Castle Biosciences, Optos Inc., Santen, EyePoint Pharmaceuticals, and Arix Biosciences.Miguel Materin serves as a consultant for Castle Biosciences.Amy Schefler serves as a consultant for Castle Biosciences (grant funding), Aura Biosciences (consultant, grant funding); Regeneron (grant funding) and Genentech (consultant, grant funding).Duncan Berry declares he has no conflict of interest.Michael I. Seider declares he has no conflict of interest.Sandra Stinnett declares she has no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the numerous Institutional Review Boards who reviewed this study (all centers listed below) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was not obtained from all individual participants included in the study as this study was retrospective and de-identified.
: The design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication were solely made by the authors without influence from the funding organizations.